Multiple myeloma, also known as myeloma, is a hematologic cancer (or cancer of the blood). Although multiple myeloma is the second most common blood cancer, after non-Hodgkin lymphoma, it is not a common cancer. The American Cancer Society estimates that 30,770 new cases of multiple myeloma will be diagnosed in 2018. Multiple myeloma is more common in men than women, and it occurs more frequently with increasing age, with the greatest incidence in those over age 70.
Multidisciplinary Multiple Myeloma Care: Models of Effective Care Delivery offers a convenient summary of recent updates in the management of this heterogeneous disease, including information on:
Plus, read how three cancer programs—a community-based comprehensive program, an academic medical center, and an NCI-designated program—are delivering multidisciplinary care to this patient population.
ACCC thanks the following member programs for their participation:
John Theurer Cancer Center at Hackensack University Medical Center
Hackensack, New Jersey
Moffitt Cancer Center
Yuma Regional Medical Center Cancer Center
The main goal of this project is to raise awareness about provider education needs related to this patient population; to establish vetted, designated resources to help fill unmet needs; to help educate the cancer care team on effective practices in caring for patients with multiple myeloma; and to foster a network of engaged community cancer care professionals.
Specifically, this project is delivering:
Funding & support provided by Amgen Oncology